Edition:
United Kingdom

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

426.15INR
11:14am BST
Change (% chg)

Rs-3.80 (-0.88%)
Prev Close
Rs429.95
Open
Rs430.00
Day's High
Rs432.75
Day's Low
Rs424.75
Volume
279,179
Avg. Vol
466,720
52-wk High
Rs678.80
52-wk Low
Rs350.40

Select another date:

Tue, Feb 12 2019

UPDATE 1-India's Sun Pharma Q3 profit jumps four-fold on strong U.S. show

Feb 12 India's largest drugmaker by market value Sun Pharmaceutical Industries Ltd posted a nearly four-fold jump in quarterly profit on Tuesday, breezing past estimates on strong sales in the U.S. market.

India's Sun Pharma Q3 profit rises nearly four-fold, beats estimate

Feb 12 Sun Pharmaceutical Industries Ltd , India's largest drugmaker by market value, posted a nearly four-fold jump in quarterly profit on Tuesday, beating estimates.

UPDATE 2-India's Sun Pharma takes steps to ease governance concerns; shares rally

* Shares jump over 6 pct (Adds analyst comments, updates share move)

India's Sun Pharma to make unit distributor for local formulations biz

Jan 22 Indian drugmaker Sun Pharmaceutical Industries Ltd said https://www.nseindia.com/corporate/SUNPHARMA456_22012019083723_IntimationSE20190122_001.pdf on Tuesday it will make its unit the new distributor for its domestic formulations business, replacing Aditya Medisales.

India's Sun Pharma tumbles on reports of fresh whistleblower complaint

Shares of Sun Pharmaceutical Industries Ltd plunged 13 percent on Friday to near six-year lows, hit by reports that a whistleblower filed a complaint to regulators over transactions involving the top Indian drugmaker and its co-promotor.

India's Sun Pharma asks regulator to examine media report

Sun Pharmaceutical Industries Ltd on Friday asked India's capital markets regulator to look into a media report about an alleged complaint by a whistleblower that led to a sell-off in the company's shares.

India's Sun Pharma asks regulator to examine media report

Jan 18 Sun Pharmaceutical Industries Ltd on Friday asked India's capital markets regulator to look into a media report about an alleged complaint by a whistleblower that led to a sell-off in the company's shares.

Select another date: